What changed
$BNS — BUY 📊 | 6 MONTHS THESIS
🎯 latest | Rev $9.6B | EPS $2.02 vs $1.94 🟢
💡 Market expects modest earnings growth and rising credit risks from international exposure. Variant view: the beat signals margin resilience and credit discipline, and consensus FY2025/FY2026 EPS estimates are too low by 3-5%, providing a repricing catalyst.
📉 Reward/risk: 2.5:1
🏢 Business Quality: 7/10 - Well-diversified Canadian bank with strong domestic franchise; international operations add growth but also currency and political risk.
📊 Valuation: cheap — P/E 10.3x vs. peer avg 11.5x; P/B ~1.2x vs. 5-year historical 1.4x; supported by FCF yield >10% and DCF implies 20% upside under conservative...
🔮 Catalyst: Post-earnings analyst estimate revisions following Q4 2025 beat
💰 Entry: $84.31, stop $80.0, target $95.0
📊 Our read: BUY. Full analysis →
https://stockduty.xyz/s/BNS0615